Literature DB >> 27713884

Resistance mechanisms.

Yasemin Cag1, Hulya Caskurlu1, Yanyan Fan2, Bin Cao3, Haluk Vahaboglu1.   

Abstract

By definition, the terms sepsis and septic shock refer to a potentially fatal infectious state in which the early administration of an effective antibiotic is the most significant determinant of the outcome. Because of the global spread of resistant bacteria, the efficacy of antibiotics has been severely compromised. S. pneumonia, Escherichia coli (E. coli), Klebsiella, Acinetobacter, and Pseudomonas are the predominant pathogens of sepsis and septic shock. It is common for E. coli, Klebsiella, Acinetobacter and Pseudomonas to be resistant to multiple drugs. Multiple drug resistance is caused by the interplay of multiple resistance mechanisms those emerge via the acquisition of extraneous resistance determinants or spontaneous mutations. Extended-spectrum beta-lactamases (ESBLs), carbapenemases, aminoglycoside-modifying enzymes (AMEs) and quinolone resistance determinants are typically external and disseminate on mobile genetic elements, while porin-efflux mechanisms are activated by spontaneous modifications of inherited structures. Porin and efflux mechanisms are frequent companions of multiple drug resistance in Acinetobacter and P. aeruginosa, but only occasionally detected among E. coli and Klebsiella. Antibiotic resistance became a global health threat. This review examines the major resistance mechanisms of the leading microorganisms of sepsis.

Entities:  

Keywords:  Acinetobacter; Escherichia coli (E. coli); Klebsiella; Pseudomonas; beta-lactamases; carbapenemase; drug resistance, multiple; septic; shock

Year:  2016        PMID: 27713884      PMCID: PMC5050191          DOI: 10.21037/atm.2016.09.14

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  78 in total

Review 1.  Bacterial enzymatic resistance: beta-lactamases and aminoglycoside-modifying enzymes.

Authors:  K Bush; G H Miller
Journal:  Curr Opin Microbiol       Date:  1998-10       Impact factor: 7.934

2.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

Review 4.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

5.  Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.

Authors:  Takashi Ode; Ryoichi Saito; Wakako Kumita; Kenya Sato; Shu Okugawa; Kyoji Moriya; Kazuhiko Koike; Noboru Okamura
Journal:  Int J Antimicrob Agents       Date:  2009-06-27       Impact factor: 5.283

6.  Molecular mechanisms of antibiotic resistance.

Authors:  Gerard D Wright
Journal:  Chem Commun (Camb)       Date:  2011-02-01       Impact factor: 6.222

7.  Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc.

Authors:  P Hejnar; M Kolár; V Hájek
Journal:  Acta Univ Palacki Olomuc Fac Med       Date:  1999

Review 8.  Methicillin-resistant staphylococci.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 9.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

Review 10.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

View more
  17 in total

1.  Why Antibiotic Treatment Is Not Enough for Sepsis Resolution: an Evaluation in an Experimental Animal Model.

Authors:  Jonathan L Halbach; Andrew W Wang; Dennis Hawisher; David M Cauvi; Radhames E Lizardo; Joseph Rosas; Tony Reyes; Omar Escobedo; Stephen W Bickler; Raul Coimbra; Antonio De Maio
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

2.  An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.

Authors:  Martina Koeva; Alina D Gutu; Wesley Hebert; Jeffrey D Wager; Lael M Yonker; George A O'Toole; Frederick M Ausubel; Samuel M Moskowitz; Diane Joseph-McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

3.  Identification of Promoter Region Markers Associated With Altered Expression of Resistance-Nodulation-Division Antibiotic Efflux Pumps in Acinetobacter baumannii.

Authors:  Mireia López-Siles; Michael J McConnell; Antonio J Martín-Galiano
Journal:  Front Microbiol       Date:  2022-05-19       Impact factor: 6.064

4.  Extended-spectrum-beta-lactamases and carbapenemase-producing Klebsiella pneumoniae isolated from fresh produce farms in different governorates of Egypt.

Authors:  Esraa A Elshafiee; Mona Kadry; Sara Mohamed Nader; Zeinab S Ahmed
Journal:  Vet World       Date:  2022-05-18

Review 5.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

6.  Characterization of a novel class A carbapenemase PAD-1 from Paramesorhizobium desertii A-3-ET, a strain highly resistant to β-lactam antibiotics.

Authors:  Ruichen Lv; Jingyu Guo; YanFeng Yan; Rong Chen; Lisheng Xiao; Min Wang; Nan Fang; Chengxiang Fang; Yujun Cui; Ruifu Yang; Yajun Song
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 7.  Bacteria from Animals as a Pool of Antimicrobial Resistance Genes.

Authors:  Maria Angeles Argudín; Ariane Deplano; Alaeddine Meghraoui; Magali Dodémont; Amelie Heinrichs; Olivier Denis; Claire Nonhoff; Sandrine Roisin
Journal:  Antibiotics (Basel)       Date:  2017-06-06

8.  Antimicrobial Evaluation of Latex and TLC Fractions from the Leaves of Aloe adigratana Reynolds.

Authors:  Demoze Asmerom; Gebremedhin Solomon Hailu; Ebrahim M Yimer; Helen Bitew; Getu Kahsay
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-27       Impact factor: 2.629

Review 9.  Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium.

Authors:  Vânia Santos Braz; Karine Melchior; Cristiano Gallina Moreira
Journal:  Front Cell Infect Microbiol       Date:  2020-12-21       Impact factor: 5.293

10.  Antimicrobial and Antibiofilm Activity and Machine Learning Classification Analysis of Essential Oils from Different Mediterranean Plants against Pseudomonas aeruginosa.

Authors:  Marco Artini; Alexandros Patsilinakos; Rosanna Papa; Mijat Božović; Manuela Sabatino; Stefania Garzoli; Gianluca Vrenna; Marco Tilotta; Federico Pepi; Rino Ragno; Laura Selan
Journal:  Molecules       Date:  2018-02-23       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.